Results 91 to 100 of about 2,710 (195)

Ozurdex bei Irvine-Gass-Syndrom

, 2016
Hintergrund: In der Therapie des Irvine-Gass-Syndroms stand bisher als intravitreale „Off-label“ Therapie das Triamcinolon zur Verfügung. Durch die Entwicklung von Ozurdex (Firma Allergan) ist eine weitere „Off-label“ Therapieoption hinzugekommen. Methoden: [zum vollständigen Text gelangen Sie über die oben angegebene URL]
Krause, D, Krause, S
openaire   +2 more sources

Dislocation of the ozurdex implant into the anterior chamber (case of reposition) [PDF]

, 2023
The purpose of the study is to report a case of migration of the dexamethasone Ozurdex implant into the anterior chamber in a patient with pseudophakia and avitria and the method of reposition.Цель исследования – cообщить о случае миграции имплантата ...
Sviridova, M. B., Куркова, Д. О., Grinev, A. G., Гринев, А. Г., Данилов, А. М., Kurkova, D. O., Danilov, A. M., Свиридова, М. Б.   +7 more
core  

Active removal of anterior segment-migrated dexamethasone implant (Ozurdex®)

, 2022
Background: Ozurdex® (Allergan plc., Dublin, Ireland) is an intravitreal sustained-release dexamethasone (DEX) implant. The implant has been reported to migrate into the anterior chamber, potentially causing corneal decompensation.
Depla, JAM, Bleyen, I, Veckeneer, M
core   +1 more source

REPEATED INTRAVITREAL DEXAMETHASONE IMPLANT (OZURDEX) FOR DIABETIC MACULAR EDEMA

, 2015
Purpose: To evaluate the effects of repeated intravitreal dexamethasone implant. Methods: We reviewed the charts of 12 patients with diabetic macular edema, who received at least 2 intravitreal Ozurdex (0.7 mg) on an "as needed" basis.
La Spina C, Scaramuzzi M, Lattanzio R, QUERQUES , GIUSEPPE, BANDELLO , FRANCESCO   +4 more
core   +1 more source

Intravitreal Dexamethasone Implant (Ozurdex) for Ocular Toxocariasis

Journal of Ophthalmology
This study aimed to evaluate the efficacy and safety of intravitreal dexamethasone implants in the treatment of ocular toxocariasis (OT). A retrospective analysis was performed on 6 cases in which laboratory tests diagnosed OT. All patients were administered with intravitreal dexamethasone implants with or without vitrectomy. The average follow‐up time
Yongwei Zhou, Fangyuan Zhen, Jiahui Wu, Shasha Wang, Xiaoyan Lu, Ge Yang, Zhirou Hu, Fei Chen, Qiuming Li, Shuqian Dong   +9 more
openaire   +3 more sources

Incomplete scleral penetration of dexamethasone (Ozurdex) intravitreal implant

BMJ Case Reports, 2018
Ozurdex (Allergan, Irvine, California, USA) is a biodegradable sustained release intravitreal implant containing 0.7 mg dexamethasone in a solid polymer drug delivery system. In the UK, it is approved for use in patients with macular oedema secondary to retinal vein occlusion, diabetic maculopathy and non-infectious uveitis.
Thomas, Sherman, Vasant, Raman
openaire   +3 more sources

MOESM1 of Ozurdex (dexamethasone intravitreal implant) for the treatment of intermediate, posterior, and panuveitis: a systematic review of the current evidence

, 2020
Additional file 1: Figure 1. Changes in Central Retinal Thickness Across Studies. Figure 2. The Average Improvement in Visual Acuity (logMAR) per Study. Figure 3. The Prevalence of Adverse Effects. Figure 4.
Chloe Gottlieb (3764347), Saanwalshah Saincher (8284608)   +1 more
core   +1 more source

Immortal Ozurdex: A 10-month follow-up of an intralenticular implant [PDF]

, 2017
A 78-year-old male who had received a dexamethasone implant (Ozurdex, Allergan, Inc., Irvine, CA, USA) 15 days back for recalcitrant diabetic macular edema in the left eye came to us for a second opinion.
Rohit Shetty, Vinod B M Kumar, Naresh Kumar Yadav, NareshKumar Yadav, Chaitra Jayadev, B Poornachandra, SubashchandraH Dorelli, VinodB M Kumar, Subashchandra H Dorelli   +8 more
core   +1 more source

Microvascular Changes after Epiretinal Membrane Vitrectomy with Intraoperative Intravitreal Dexamethasone Implant: An OCT Angiography Analysis

Diagnostics
Background: We aimed to explore microvascular changes evaluated with optical coherence tomography angiography (OCTA) in patients undergoing epiretinal membrane (ERM) pars-plana vitrectomy (PPV) combined with intravitreal Ozurdex implantation, compared ...
Antonio Baldascino, Matteo Mario Carlà, Lorenzo Vielmo, Gloria Gambini, Francesca Carolina Marzano, Fabio Margollicci, Nicola Claudio D’Onofrio, Stanislao Rizzo   +7 more
doaj   +1 more source

Advances in diabetic retinopathy

Indian Journal of Endocrinology and Metabolism, 2014
Diabetic retinopathy (DR) is a complication of long-term diabetes mellitus (DM). Over the last 2 decades lot of work has been on early diagnosis of DR and screening programs have been designed to help the masses.
Prakashchand Agarwal, Ankita Jindal, V K Saini, Sushil Jindal   +3 more
doaj   +1 more source